日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pathology of a Canine Model of Localized Prostate Carcinoma.

犬局限性前列腺癌模型的病理学研究。

Hoggard Nathan K, Berg Felipe M, Szczepaniak Marlon R, Wang Xinning, Kantake Noriko, Ramamurthy Gopalakrishnan, Gong Li, Hostnik Eric T, Kumar Krishan, Ghosh Arijit, Luo Dong, Knopp Michael V, Keller Jill M, Keller Evan T, Exner Agata A, Basilion James P, Tweedle Michael F, Rosol Thomas J

Redefining cancer photodynamic therapy with gold nanoparticles

利用金纳米粒子重新定义癌症光动力疗法

Lockwood, Zoey A; Jirousek, Michael R; Basilion, James P; Burda, Clemens

PSMA-1-DOTA Potentially for Effective Targeted Radioligand Therapy of Prostate Cancer

PSMA-1-DOTA 有望成为前列腺癌的有效靶向放射性配体疗法

Wang, Xinning; Sergeeva, Olga; Sergeev, Maxim; Zhang, Lifang; Lockwood, Zoey; Wojtylak, Patrick; Sangster, Riley; Reichert, David; Berridge, Marc; Weber, Wolfgang; Lee, Zhenghong; Basilion, James P

Ex vivo fluorescence-guided resection margin assessment in breast cancer surgery using a topically applied, cathepsin-activatable imaging agent.

利用局部应用的组织蛋白酶激活成像剂进行乳腺癌手术中离体荧光引导切缘评估

Linders Daan G J, Bijlstra Okker D, Walker Ethan, March Taryn L, Pool Martin, Valentijn A Rob P M, Dijkhuis Tom H, Woltering Jikke N, Pijl Floor R, Noordam Gilbert, van den Burg Davey, van der Sijp Joost R M, Guicherit Onno R, Marinelli Andreas W K S, Burggraaf Jacobus, Rissmann Robert, Bogyo Matthew, Hilling Denise E, Kuppen Peter J K, Straight Brian, Straver Marieke E, Hazelbag Hans Marten, Basilion James P, Vahrmeijer Alexander L

A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer

化疗与光动力疗法相结合的协同策略根除前列腺癌

Shirke, Aditi A; Walker, Ethan; Chavali, Sriprada; Ramamurthy, Gopalakrishnan; Zhang, Lifang; Panigrahi, Abhiram; Basilion, James P; Wang, Xinning

Applications of Au(25) Nanoclusters in Photon-Based Cancer Therapies

Au(25)纳米团簇在光子癌症治疗中的应用

Lockwood, Zoey A; Jirousek, Michael R; Basilion, James P; Burda, Clemens

Immunohistochemical Evaluation of Cathepsin B, L, and S Expression in Breast Cancer Patients

乳腺癌患者组织蛋白酶 B、L 和 S 表达的免疫组织化学评估

Daan G J Linders, Okker D Bijlstra, Laura C Fallert, N Geeske Dekker-Ensink, Taryn L March, Martin Pool, Ethan Walker, Brian Straight, James P Basilion, Matthew Bogyo, Jacobus Burggraaf, Denise E Hilling, Alexander L Vahrmeijer, Peter J K Kuppen, A Stijn L P Crobach2

Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse Model

同基因乳腺癌小鼠模型中的前列腺特异性膜抗原表达

Aditi A Shirke, Jing Wang, Gopolakrishnan Ramamurthy, Arpan Mahanty, Ethan Walker, Lifang Zhang, Abhiram Panigrahi, Xinning Wang, James P Basilion

Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands

在唾液腺中寻找前列腺特异性膜抗原靶向放射性配体的脱靶蛋白

Julian, William; Sergeeva, Olga; Cao, Wei; Wu, Chunying; Erokwu, Bernadette; Flask, Chris; Zhang, Lifang; Wang, Xinning; Basilion, James; Yang, Sichun; Lee, Zhenghong

GCP III is not the "off-target" for urea-based PSMA ligands

GCP III 不是基于尿素的 PSMA 配体的“脱靶”靶点。

Lee, Zhenghong; Heston, Warren D; Wang, Xinning; Basilion, James P